Captrust Financial Advisors Amedisys Inc Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$91.15 - $95.89 $14,766 - $15,534	162 Added 6.1%	2,819 $267,000
Q3 2023 Nov 14, 2023	SELL	$89.84 - $94.08 $564,374 - $591,010	-6,282 Reduced 70.28%	2,657 $248,000
Q2 2023 Aug 14, 2023	SELL	$73.99 - $92.6 $18,275 - $22,872	-247 Reduced 2.69%	8,939 $817,000
Q1 2023 May 15, 2023	BUY	$69.79 - $100.33 $45,433 - $65,314	651 Added 7.63%	9,186 $675,000
Q4 2022 Feb 15, 2023	BUY	$80.12 - $105.34 $209,994 - $276,096	2,621 Added 44.32%	8,535 $713,000
Q3 2022 Nov 16, 2022	SELL	$96.79 - $131.14 $50,427 - $68,323	-521 Reduced 8.1%	5,914 $572,000
Q2 2022 Aug 23, 2022	SELL	$105.12 - $173.85 $27,646 - $45,722	-263 Reduced 3.93%	6,435 $676,000
Q2 2022 Aug 16, 2022	BUY	$105.12 - $173.85 $140,124 - $231,742	1,333 Added 24.85%	6,698 $704,000
Q1 2022 May 16, 2022	BUY	$124.79 - $178.09 $223,998 - $319,671	1,795 Added 50.28%	5,365 $924,000
Q4 2021 Feb 14, 2022	SELL	$136.32 - $184.41 $76,066 - $102,900	-558 Reduced 13.52%	3,570 $578,000
Q3 2021 Nov 16, 2021	SELL	$149.1 - $270.32 $356,349 - $646,064	-2,390 Reduced 36.67%	4,128 $615,000
Q2 2021 Aug 16, 2021	SELL	$238.97 - $288.5 $360,366 - $435,058	-1,508 Reduced 18.79%	6,518 $1.6 Million
Q1 2021 May 17, 2021	BUY	$236.62 - $314.16 $147,650 - $196,035	624 Added 8.43%	8,026 $2.13 Million
Q4 2020 Feb 16, 2021	SELL	$231.3 - $293.33 $76,097 - $96,505	-329 Reduced 4.26%	7,402 $2.17 Million
Q3 2020 Nov 17, 2020	SELL	$199.22 - $248.1 $5,777 - $7,194	-29 Reduced 0.37%	7,731 $1.82 Million
Q2 2020 Aug 14, 2020	SELL	$169.77 - $213.81 $679 - $855	-4 Reduced 0.05%	7,760 $1.6 Million
Q1 2020 May 15, 2020	BUY	$137.21 - $202.02 $4,116 - $6,060	30 Added 0.39%	7,764 $1.34 Million
Q4 2019 Feb 14, 2020	BUY	$122.85 - $167.13 $848,770 - $1.15 Million	6,909 Added 837.45%	7,734 $1.29 Million
Q3 2019 Nov 14, 2019	BUY	$117.97 - $137.89 $8,847 - $10,341	75 Added 10.0%	825 $108,000
Q2 2019 Aug 13, 2019	BUY	$108.08 - $129.67 $16,536 - $19,839	153 Added 25.63%	750 $91,000
Q4 2018 Feb 13, 2019	BUY	$98.2 - $140.23 $36,235 - $51,744	369 Added 161.84%	597 $70,000
Q3 2018 Nov 15, 2018	SELL	$87.74 - $125.01 $9,300 - $13,251	-106 Reduced 31.74%	228 $28,000
Q2 2018 Aug 13, 2018	SELL	$60.06 - $87.93 $900 - $1,318	-15 Reduced 4.3%	334 $29,000
Q1 2018 May 15, 2018	BUY	$50.51 - $62.74 $6,162 - $7,654	122 Added 53.74%	349 $21,000
Q4 2017 Feb 14, 2018	BUY	$46.45 - $58.49 $10,544 - $13,277	227	227 $12,000

Others Institutions Holding AMED

# of Institutions

297

Shares Held

28.5M

Call Options Held

181K

Put Options Held

1.04M

Vanguard Group Inc Valley Forge, PA

3.21M
Shares

$295 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.1M
Shares

$285 Million
0.01% of portfolio
Fil LTD Hamilton, D0

1.31M
Shares

$120 Million
0.12% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.12M
Shares

$103 Million
5.22% of portfolio
Pentwater Capital Management LP Naples, FL

1.08M
Shares

$98.8 Million
1.08% of portfolio

View Full List

About AMEDISYS INC

Ticker AMED
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 32,492,000
Market Cap $2.99B
Description
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...

More about AMED

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account